Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Ligand Pharm
(NQ:
LGND
)
86.40
+1.49 (+1.75%)
Streaming Delayed Price
Updated: 4:00 PM EDT, May 24, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Ligand Pharm
< Previous
1
2
3
4
5
Next >
Ligand Pharmaceuticals Stock Shows Market Leadership With Jump To 82 RS Rating
September 20, 2021
Ligand Pharmaceuticals stock saw a positive improvement to its Relative Strength (RS) Rating on Monday, rising from 71 to 82.
Via
Investor's Business Daily
Why Digital Turbine's Stock Is Trading Higher Today
August 31, 2021
Digital Turbine Inc (NASDAQ: APPS) is trading higher Tuesday after it was announced the company is set to join the S&P MidCap 400. Digital Turbine will replace ...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Digital Turbine Added To S&P MidCap 400 Index
August 31, 2021
Media and mobile communications company Digital Turbine Inc (NASDAQ:
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Ligand’s Partner Gloria Biosciences Receives Approval in China for Zimberelimab for the Treatment of Recurrent or Refractory Classical Hodgkin’s Lymphoma
August 30, 2021
From
Ligand Pharmaceuticals Incorporated
Via
Business Wire
The Daily Biotech Pulse: VectivBio In M&A Mix, Sonnet Biotherapeutics Advances Candidate To Clinics, CEO Transitions At Galapagos, Talis Biomedical
August 31, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 26) Agenus Inc. (NASDAQ: AGEN)...
Via
Benzinga
Ligand Partner Travere Therapeutics Announces Positive Topline Interim Results from the Ongoing Phase 3 PROTECT Study of Sparsentan in IgA Nephropathy
August 16, 2021
From
Ligand Pharmaceuticals
Via
Business Wire
What To Know About Rand Paul Failing To Disclose Gilead Stock Purchase For 16 Months
August 12, 2021
Stock transactions by members of the U.S. Congress and their spouses have been a hot topic over the last several years. A transaction disclosed late Wednesday is drawing heavy...
Via
Benzinga
Ligand Pharmaceuticals Incorporated (LGND) Q2 2021 Earnings Call Transcript
July 30, 2021
LGND earnings call for the period ending June 30, 2021.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
Ligand Reports Second Quarter 2021 Financial Results
July 29, 2021
From
Ligand Pharmaceuticals Incorporated
Via
Business Wire
Ligand Partner Jazz Pharmaceuticals Launches RYLAZE™ (asparaginase erwinia chrysanthemi (recombinant)-rywn), Formerly JZP458
July 21, 2021
From
Ligand Pharmaceuticals Incorporated
Via
Business Wire
The Daily Biotech Pulse: Merck's Disappointing Q2, Atreca Falls On Data, FDA Nod For Viatris, Nuvalent, Icosavax IPOs
July 29, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 28) AbbVie Inc. (NYSE: ABBV)...
Via
Benzinga
Exposures
Product Safety
The Week Ahead In Biotech (July 25-31): Big Pharma Earnings, Iterum FDA Decision, Alzheimer's Conference, IPOs and More
July 25, 2021
Biotech stocks rebounded in the week ended July 23, thanks to the broader market strength. The sector also benefitted from the optimism that was set in motion by the solid start...
Via
Benzinga
Exposures
Product Safety
Ligand’s Partner Merck Receives FDA Approval for VAXNEUVANCE™ for the Prevention of Invasive Pneumococcal Disease in Adults Caused by 15 Serotypes
July 19, 2021
From
Ligand Pharmaceuticals Incorporated
Via
Business Wire
The Week Ahead In Biotech: Earnings Kickstart With J&J And Biogen, Albireo Awaits FDA Decisions, More IPOs
July 18, 2021
Biotech stocks were down for a second week in a row, as they retreated along with the broader market amid macro concerns. Consumer price inflation data released during the week...
Via
Benzinga
Exposures
Product Safety
Ligand to Report Second Quarter Financial Results on July 29, 2021
July 16, 2021
From
Ligand Pharmaceuticals Incorporated
Via
Business Wire
Ligand Pharmaceuticals Appoints Dr. Jennifer Cochran to its Board of Directors
July 14, 2021
From
Ligand Pharmaceuticals Incorporated
Via
Business Wire
Attention Biotech Investors: Mark Your Calendar For July PDUFA Dates
July 01, 2021
June was a month of plenty and also turned out to be a fruitful one from the perspective of Food and Drug Administration approvals. Regulatory reviews mostly produced positive...
Via
Benzinga
When Cap-Weighted Small-Cap Funds Own “Meme” Stocks
May 13, 2021
I cannot say whether GameStop or the other meme stocks will get their businesses back on their feet. What I can say is that, if you are tracking various small-cap indexes, you just might own them, like...
Via
Talk Markets
Ligand's Revenue Soars in Q1 Thanks to Gilead's COVID Drug
May 04, 2021
The drugmaker is also looking for its highest sales ever in 2021 in large part because of remdesivir.
Via
The Motley Fool
Ligand Pharmaceuticals Inc (LGND) Q1 2021 Earnings Call Transcript
May 04, 2021
LGND earnings call for the period ending March 31, 2021.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
The Daily Biotech Pulse: Vaxart Rebounds On Strong Vaccine Data, Pfizer's Beat-And-Raise Quarter, BioLineRx Data
May 04, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 3) AbbVie Inc. (NYSE: ABBV)...
Via
Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
May 03, 2021
Gainers Precipio (NASDAQ:
Via
Benzinga
Recap: Ligand Pharmaceuticals Q1 Earnings
May 03, 2021
Shares of Ligand Pharmaceuticals (NASDAQ:LGND) fell 7% in after-market trading after the company reported Q1 results. Quarterly Results Earnings per share were up 58.43% over the...
Via
Benzinga
Ligand Reports First Quarter 2021 Financial Results
May 03, 2021
From
Ligand Pharmaceuticals Incorporated
Via
Business Wire
Short Interest Report: B&G Foods Short Position At Three-Month Highs
April 30, 2021
Estimated short interest in B&G Foods has accelerated its gains, spiking on Monday and also rising for four out of five trading sessions. For the week, B&G Foods short interest was up 22% at 28.94% of...
Via
Talk Markets
Ligand to Report First Quarter Financial Results on May 3, 2021
April 22, 2021
From
Ligand Pharmaceuticals Incorporated
Via
Business Wire
Earnings Scheduled For May 3, 2021
May 03, 2021
Companies Reporting Before The Bell • Scienjoy Holding (NASDAQ:SJ) is estimated to report quarterly earnings at $0.58 per share on revenue of $540.11 million. •...
Via
Benzinga
3 Signs the Ligand Short Squeeze Is Over
April 22, 2021
The Reddit crowd wasn't the only reason short-sellers got burned betting against this pharmaceutical company.
Via
The Motley Fool
< Previous
1
2
3
4
5
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.